Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea (Q83329973)
Jump to navigation
Jump to search
scientific article published on 01 January 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea |
scientific article published on 01 January 2009 |
Statements
Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea (English)
Andrew Lewin
Timothy Bailey
Denise Chang
Titus Gylvin
Victor Roberts
NovoLog Mix-vs.-Exenatide Study Group
1 January 2009